Unbranded HCP APS
Hypothetically, might it be acceptable to develop an unbranded APS directed to HCP with an educational focus on an emerging therapeutic technology, given that i) the APS would have no mention of or linkage to any condition or therapeutic area, ii) the technology is not exclusively applied to one therapeutic area, and iii) such technology is already utilized in pharmaceuticals that have been approved in Canada?
Jennifer Carroll last edited by
This sounds like it might be possible in an APS that is both product and disease agnostic but it is difficult to say with confidence without knowing the emerging technology, it’s approved applications, the discussions within the piece and their implications to current or future therapeutic areas etc. If the specific example cannot be provided in a public forum, an opinion may be a better option.